Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor.

Stensgaard, Simone; Thomsen, Astrid; Helstrup, Sofie; Meldgaard, Peter; Sorensen, Boe S

Stensgaard, Simone; Thomsen, Astrid; Helstrup, Sofie; Meldgaard, Peter; Sorensen, Boe S.

Afiliación

Stensgaard S; Department of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, Denmark.
Thomsen A; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.
Helstrup S; Department of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, Denmark.
Meldgaard P; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.
Sorensen BS; Department of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, Denmark.

Cancers (Basel) ; 15(23)2023 Nov 29.

Article en En | MEDLINE | ID: mdl-38067332

Palabras clave

biomarkers; circulating tumor DNA; immune checkpoint inhibitor; immuno-oncology; immunotherapy; non-small-cell lung cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google